Why Choose Private Prescription for Weight Loss Treatment?
Private Prescription Access: Wegovy or Mounjaro for Weight Loss Without NHS Delays
The NHS route for accessing Wegovy or Mounjaro for weight loss involves multiple hurdles that can delay treatment for months. Patients must first obtain a GP referral to specialist weight management services, then navigate strict eligibility criteria and lengthy waiting lists that often exceed six months. Many discover their local CCG has limited funding or restrictive protocols that further complicate access. Private prescription eliminates these barriers entirely, providing direct access to the same prescription-only medicines through qualified healthcare professionals.
EverydayMeds offers both Wegovy and Mounjaro through our streamlined private service, allowing patients to begin treatment within 24-48 hours of assessment approval. Our prescribers evaluate your medical history, current medications, and weight management goals to recommend whether Wegovy's GLP-1 mechanism or Mounjaro's dual GIP+GLP-1 approach better suits your needs. This personalised approach ensures you receive the most appropriate treatment without the frustration of NHS gatekeeping or postcode lottery restrictions.
Transparent Pricing: Compare Wegovy or Mounjaro for Weight Loss Costs
Understanding the true cost of private Wegovy or Mounjaro for weight loss helps you budget effectively for long-term treatment. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first two months of treatment in one convenient order.
Mounjaro follows a similar dose escalation pattern with competitive pricing across all strength options. Both treatments require gradual dose increases over 16-20 weeks to minimise side effects and optimise efficacy. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 to access our promotional pricing. This transparent approach helps you plan your weight management investment without hidden costs or surprise charges that some private clinics impose.
Clinical Evidence: How Wegovy or Mounjaro for Weight Loss Performs in Trials
Clinical trials demonstrate impressive efficacy for both Wegovy and Mounjaro in supporting weight management alongside reduced-calorie diets and increased physical activity. The STEP programme evaluated semaglutide (Wegovy) across multiple populations, with STEP 1 showing participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 focused on patients with type 2 diabetes, demonstrating around 9.6% weight reduction, while STEP 3 combined treatment with intensive behavioural therapy for approximately 16% average weight loss.
Mounjaro's SURMOUNT trials examined tirzepatide's dual GIP+GLP-1 mechanism, revealing substantial weight reductions across different patient populations. However, comparing trial results directly between Wegovy or Mounjaro for weight loss can be misleading due to different study designs, populations, and endpoints. Both treatments work through appetite regulation and enhanced satiety, but individual responses vary significantly based on genetics, lifestyle factors, and adherence to prescribed diet and exercise modifications.
Understanding How Wegovy Works for Weight Loss Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone your intestines produce after eating. This prescription-only medicine works primarily in the brain's appetite centres, reducing hunger signals and enhancing feelings of fullness after smaller meals. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety between meals. Many patients report reduced food cravings, particularly for high-calorie foods, though individual experiences vary considerably. Wegovy must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal weight management results, as the medication enhances but doesn't replace healthy lifestyle modifications.
Simple Ordering Process: Get Wegovy or Mounjaro for Weight Loss Privately
Accessing Wegovy or Mounjaro for weight loss through EverydayMeds involves a straightforward three-step process designed for busy lifestyles. Complete our 3-minute online clinical assessment covering your medical history, current medications, previous weight loss attempts, and treatment goals. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), evaluating your suitability for either treatment option. Once approved, your prescription-only medicine ships via next-day cold-chain delivery to maintain the temperature-controlled storage requirements both medications demand. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet the same quality standards as NHS prescriptions while providing the convenience and speed private healthcare offers.
Storage and Practical Considerations for Weight Loss Injections
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks room temperature storage (below 30°C) compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy more suitable for frequent travellers or those with unpredictable schedules. Both medications use pre-filled pen injectors - Wegovy's FlexTouch pen and Mounjaro's KwikPen - designed for once-weekly subcutaneous injection into the abdomen, thigh, or upper arm. Dose escalation follows a mandatory schedule over 16-20 weeks, gradually increasing from starter doses to maintenance levels. Patients cannot skip dose levels, as this increases the risk of gastrointestinal side effects that may compromise treatment adherence and effectiveness.
Choosing Between Wegovy or Mounjaro for Weight Loss: Key Differences
The fundamental difference between Wegovy or Mounjaro for weight loss lies in their mechanisms of action and regulatory pathways. Wegovy utilises semaglutide's selective GLP-1 receptor agonism, while Mounjaro employs tirzepatide's dual GIP and GLP-1 receptor activation. This dual mechanism may offer additional metabolic benefits, though both treatments require careful prescriber evaluation to determine individual suitability. Wegovy holds NICE recommendation TA875 for NHS use with specialist weight management support, while Mounjaro follows different regulatory timelines.
Patient preference often influences choice between these options, considering factors like injection frequency (both weekly), storage requirements, and individual response patterns. Some patients respond better to single-pathway GLP-1 activation, while others may benefit from dual incretin effects. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical profile and weight management objectives.
Start Your Weight Loss Journey Today
Don't let NHS waiting lists delay your weight management goals when effective treatments are available privately. Whether you choose Wegovy or Mounjaro for weight loss, EverydayMeds provides expert prescriber guidance and next-day delivery to begin your transformation journey. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 for promotional pricing on all dose strengths. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and discover which treatment suits your needs best. Our experienced clinical team supports your success with ongoing guidance and convenient prescription management. Take control of your weight loss journey with professional medical supervision and genuine prescription-only medicines delivered discreetly to your door.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
